首页> 美国卫生研究院文献>Anais Brasileiros de Dermatologia >Oxybutynin as an alternative treatment for hyperhidrosis
【2h】

Oxybutynin as an alternative treatment for hyperhidrosis

机译:奥昔布宁作为多汗症的替代治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. The exact cause of primary focal hyperhidrosis is still unknown, although a genetic basis is recognized, and its prevalence varies from 1% to 2.8%. The most affected sites are the armpits, palms, soles and face. It causes much discomfort, affects the quality of life, and is estimated to be undervalued by health professionals. Many treatment options are proposed, both clinical and surgical. The aim of this review is to focus on the treatment of hyperhidrosis with oxybutynin, an anticholinergic drug originally used to control overactive bladder.
机译:多汗症是出汗的过量产生,出汗可能是各种病理的原发性和局灶性或继发性。尽管公认的遗传基础,原发灶性多汗症的确切原因仍是未知的,其患病率从1%到2.8%不等。受影响最大的部位是腋窝,手掌,脚掌和脸部。它会引起很多不适感,影响生活质量,并且估计会被医疗专业人员低估。提出了许多治疗选择,包括临床和外科治疗。这篇综述的目的是集中于用奥昔布宁治疗多汗症,奥昔布宁是一种最初用于控制膀胱过度活动症的抗胆碱能药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号